IDEAYA Biosciences Announces Participation in Jefferies London Healthcare Conference and Plans for Investor R&D Day
IDEAYA Biosciences (NASDAQ: IDYA) announced its upcoming participation in two key events: the Jefferies London Healthcare Conference on November 19th, 2024, featuring a fireside chat with CEO Yujiro S. Hata, and an Investor R&D Day scheduled for December 16th, 2024. The R&D Day will showcase IDEAYA's potential first-in-class preclinical and clinical pipeline, featuring presentations from management, Key Opinion Leaders, and pharmaceutical partners. Both events will be accessible via webcast through IDEAYA's investor relations website, with recordings available for 30 days after the live events.
IDEAYA Biosciences (NASDAQ: IDYA) ha annunciato la sua imminente partecipazione a due eventi chiave: la Jefferies London Healthcare Conference il 19 novembre 2024, con un incontro informale con il CEO Yujiro S. Hata, e un Investor R&D Day previsto per il 16 dicembre 2024. Il R&D Day metterà in mostra il potenziale pipeline preclinico e clinico di IDEAYA, con presentazioni della direzione, Leader di Opinione Chiave e partner farmaceutici. Entrambi gli eventi saranno accessibili tramite webcast sul sito web delle relazioni con gli investitori di IDEAYA, con registrazioni disponibili per 30 giorni dopo gli eventi dal vivo.
IDEAYA Biosciences (NASDAQ: IDYA) anunció su próxima participación en dos eventos clave: la Jefferies London Healthcare Conference el 19 de noviembre de 2024, que contará con una charla informal con el CEO Yujiro S. Hata, y un Día de I+D para Inversores programado para el 16 de diciembre de 2024. El Día de I+D mostrará el prometedor pipeline preclínico y clínico de IDEAYA, con presentaciones de la dirección, Líderes de Opinión Clave y socios farmacéuticos. Ambos eventos estarán disponibles por webcast a través del sitio web de relaciones con inversores de IDEAYA, con grabaciones disponibles durante 30 días después de los eventos en vivo.
IDEAYA Biosciences (NASDAQ: IDYA)는 두 개의 주요 행사에 참여할 예정이라고 발표했습니다: 2024년 11월 19일 Jefferies London Healthcare Conference에서 CEO Yujiro S. Hata와의 파이어사이드 채팅이 진행되며, 2024년 12월 16일로 예정된 투자자 R&D 데이입니다. R&D 데이에서는 IDEAYA의 잠재적인 첫 번째 클래스의 전임상 및 임상 파이프라인이 소개되며, 경영진, 주요 의견 리더 및 제약 파트너의 발표가 포함됩니다. 두 행사는 IDEAYA의 투자자 관계 웹사이트를 통해 웹캐스트로 접근할 수 있으며, 생중계 후 30일 동안 녹화본이 제공됩니다.
IDEAYA Biosciences (NASDAQ: IDYA) a annoncé sa prochaine participation à deux événements clés : la Jefferies London Healthcare Conference le 19 novembre 2024, avec une discussion informelle avec le PDG Yujiro S. Hata, et un Journée R&D pour Investisseurs prévue pour le 16 décembre 2024. La journée R&D mettra en avant le pipeline préclinique et clinique prometteur d'IDEAYA, avec des présentations de la direction, des leaders d'opinion clés et des partenaires pharmaceutiques. Les deux événements seront accessibles via un webcast sur le site web des relations investisseurs d'IDEAYA, avec des enregistrements disponibles pendant 30 jours après les événements en direct.
IDEAYA Biosciences (NASDAQ: IDYA) hat seine bevorstehende Teilnahme an zwei wichtigen Veranstaltungen angekündigt: der Jefferies London Healthcare Conference am 19. November 2024, bei der ein Fireside-Chat mit CEO Yujiro S. Hata stattfinden wird, sowie einem Investoren-F&E-Tag, der für den 16. Dezember 2024 geplant ist. Der F&E-Tag wird die potenziell erste Klasse der präklinischen und klinischen Pipeline von IDEAYA präsentieren, mit Präsentationen von Management, Key Opinion Leaders und pharmazeutischen Partnern. Beide Veranstaltungen werden über einen Webcast auf der Investor-Relations-Website von IDEAYA zugänglich sein, mit Aufzeichnungen, die 30 Tage nach den Live-Events verfügbar sind.
- None.
- None.
Jefferies London Healthcare Conference
Tuesday, November 19th, 2024 at 10:00 AM GMT | 5:00 AM ET
- Fireside chat with Yujiro S. Hata, Chief Executive Officer, hosted by Maury Raycroft, Ph.D. Equity Research Analyst, Biotechnology
IDEAYA Biosciences Investor R&D Day
Monday, December 16th, 2024 at 8:00 AM ET
- The IDEAYA Investor R&D Day will highlight IDEAYA's potential first-in-class preclinical and clinical pipeline with management, leading Key Opinion Leader(s) (KOLs), and Pharma partner(s)
- Pre-registration will be available through IDEAYA's investor relations events page at https://ir.ideayabio.com/events, or https://lifescievents.com/event/ideaya-4/
A live audio webcast of the conference event, as permitted by the conference host, will be available at the "Investors/Events" section of the IDEAYA website at https://ir.ideayabio.com/events and/or through the conference host. A replay of the webcast will be accessible for 30 days following the live event.
About IDEAYA Biosciences
IDEAYA is a precision medicine oncology company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. IDEAYA's approach integrates capabilities in identifying and validating translational biomarkers with drug discovery to select patient populations most likely to benefit from its targeted therapies. IDEAYA is applying its early research and drug discovery capabilities to synthetic lethality – which represents an emerging class of precision medicine targets.
Forward-Looking Statements
This press release contains forward-looking statements, including, but not limited to, statements related to participation in and/or presentation at certain investor relations events. IDEAYA undertakes no obligation to update or revise any forward-looking statements. For a further description of the risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to the business of IDEAYA in general, see IDEAYA's current and future filings with the
Investor and Media Contact
IDEAYA Biosciences
Andres Ruiz Briseno
Senior Vice President, Head of Finance and Investor Relations
investor@ideayabio.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/ideaya-biosciences-announces-participation-in-jefferies-london-healthcare-conference-and-plans-for-investor-rd-day-302302062.html
SOURCE IDEAYA Biosciences, Inc.
FAQ
When is IDEAYA Biosciences (IDYA) hosting its Investor R&D Day in 2024?
When is IDEAYA Biosciences (IDYA) presenting at the Jefferies London Healthcare Conference?